Key Points
- Insider Ije Nwokori purchased 232 Dr. Martens shares at GBX 65 each, totaling £150.80, on September 11. This follows purchases of 179 shares in August and 118,516 shares worth £85,331.52 in June.
- Dr. Martens shares opened at GBX 66.02, with a market capitalization of approximately £631.9 million and a one-year trading range of GBX 59.15 to GBX 100.87.
- Analysts hold a consensus “Moderate Buy” rating, with an average price target of GBX 105; RBC maintains a “sector perform” rating with a GBX 100 target.
Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori bought 232 shares of the business's stock in a transaction dated Friday, September 11th. The shares were bought at an average cost of GBX 65 per share, for a total transaction of £150.80.
Ije Nwokori also recently made the following trade(s):
- On Tuesday, August 11th, Ije Nwokori purchased 179 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 84 per share, with a total value of £150.36.
- On Thursday, June 25th, Ije Nwokori purchased 118,516 shares of Dr. Martens stock. The stock was bought at an average cost of GBX 72 per share, with a total value of £85,331.52.
Dr. Martens Stock Performance
Shares of DOCS opened at GBX 66.02 on Thursday. The company has a 50-day simple moving average of GBX 76.74 and a two-hundred day simple moving average of GBX 70.48. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13. The firm has a market capitalization of £631.90 million, a PE ratio of 27.51, a price-to-earnings-growth ratio of 6.40 and a beta of 0.26. Dr. Martens plc has a one year low of GBX 59.15 and a one year high of GBX 100.87.
Analyst Upgrades and Downgrades
Separately, Royal Bank Of Canada restated a "sector perform" rating and set a GBX 100 price target on shares of Dr. Martens in a research report on Tuesday, June 2nd. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of GBX 105.
Get Our Latest Analysis on Dr. Martens
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot - named after the date it was produced - rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, "Docs" or "DM's" were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.
Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
